Sequential everolimus for angiomyolipoma associated with tuberous sclerosis complex: a prospective cohort study

被引:0
|
作者
Liangyou Gu
Cheng Peng
Fan Zhang
Cunjin Fang
Gang Guo
机构
[1] Chinese PLA General Hospital,Department of Urology, the Third Medical Centre
[2] Capital Medical University,School of Pharmacy
关键词
Angiomyolipoma; Tuberous sclerosis complex; Mutation; Everolimus; Mammalian target of rapamyoin;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Sequential everolimus for angiomyolipoma associated with tuberous sclerosis complex: a prospective cohort study
    Gu, Liangyou
    Peng, Cheng
    Zhang, Fan
    Fang, Cunjin
    Guo, Gang
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
  • [2] Intermittent everolimus administration for renal angiomyolipoma associated with tuberous sclerosis complex
    Hatano, Takashi
    Inaba, Hiroyuki
    Endo, Katsuhisa
    Egawa, Shin
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 (11) : 780 - 785
  • [3] THE EFFECT OF EVEROLIMUS IN PATIENTS WITH RENAL ANGIOMYOLIPOMA ASSOCIATED WITH TUBEROUS SCLEROSIS COMPLEX
    Robles, Nicolas R.
    Peces, Ramon
    Gomez-Ferrer, Alvaro
    Villacampa, Felipe
    Alvarez-Ossorio, Jose L.
    Perez, Pedro
    Trilla, Enrique
    Herrera, Bernardo
    Nieto, Javier
    Carballido, Joaquin
    Anido, Urbano
    Meseguer, Cristina
    Torra, Roser
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 355 - 356
  • [4] Sirolimus can promote the disappearance of renal angiomyolipoma associated with tuberous sclerosis complex: a prospective cohort study
    Dun, Shuo
    Wang, Yang-Yang
    Wan, Lin
    Wang, Qiu-Hong
    Lu, Qian
    Yang, Xiao-Yan
    Zhang, Qi
    Chen, Hui-Min
    Qiu, Lu-Peng
    Zou, Li-Ping
    [J]. WORLD JOURNAL OF PEDIATRICS, 2024, 20 (06) : 602 - 610
  • [5] Effects of everolimus on tuberous sclerosis complex-associated renal angiomyolipoma: A preliminary report
    Tsai, Jeng-Dau
    Wei, Chang-Ching
    Yang, Sheng-Hui
    Fan, Hueng-Chuen
    Hsu, Chih-Chuan
    Tung, Min-Che
    Tsai, Min-Ling
    Sheu, Ji-Nan
    [J]. NEPHROLOGY, 2017, 22 (12) : 1017 - 1022
  • [6] The impact of everolimus on hematologic parameters in patients with renal angiomyolipoma associated with tuberous sclerosis complex
    Qiu, Dongxu
    Wang, Wenda
    Zhao, Yang
    Wang, Zhan
    Wang, Xu
    Liao, Zhangcheng
    Zhang, Yushi
    [J]. DISCOVER ONCOLOGY, 2024, 15 (01)
  • [7] Everolimus for renal angiomyolipoma in tuberous sclerosis
    Sooriakumaran, Prasanna
    Anderson, Christopher J.
    [J]. LANCET, 2013, 381 (9869): : 783 - 785
  • [8] Editorial Comment to Intermittent everolimus administration for renal angiomyolipoma associated with tuberous sclerosis complex
    Shirotake, Suguru
    Nishimoto, Koshiro
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 (11) : 785 - 786
  • [9] EFFECTS OF EVEROLIMUS ON THE HUGE RENAL ANGIOMYOLIPOMA IN PATIENTS WITH TUBEROUS SCLEROSIS COMPLEX
    Mizuno, Hiroki
    Oshima, Yoichi
    Oguro, Masahiko
    Kunizawa, Kyohei
    Sekine, Akinari
    Kawada, Masahiro
    Yamanouchi, Masayuki
    Hayami, Noriko
    Hasegawa, Eiko
    Sumida, Kei-ichi
    Hoshino, Jun-ichi
    Yoshifumi, Ubara
    Takaichi, Kenmei
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 117 - 117
  • [10] Everolimus versus sirolimus for angiomyolipoma associated with tuberous sclerosis complex: a multi-institutional retrospective study in China
    Cong Luo
    Yu-Shi Zhang
    Ming-Xin Zhang
    Min-Feng Chen
    Yuan Li
    Lin Qi
    Han-Zhong Li
    Xiong-Bin Zu
    Yi Cai
    [J]. Orphanet Journal of Rare Diseases, 16